WCM
Wedge Capital Management Portfolio holdings
AUM
$5.6B
This Quarter Return
+1.9%
1 Year Return
+23.19%
3 Year Return
+97.17%
5 Year Return
+207.91%
10 Year Return
+330.87%
AUM
$9.6B
AUM Growth
+$9.6B
(+1.3%)
Cap. Flow
+$22M
Cap. Flow
% of AUM
0.23%
Top 10 Holdings %
Top 10 Hldgs %
15.95%
Holding
636
New
50
Increased
233
Reduced
252
Closed
65
Top Buys
| 1 |
Cullen/Frost Bankers
CFR
|
$79.9M |
| 2 |
Gilead Sciences
GILD
|
$40.5M |
| 3 |
AbbVie
ABBV
|
$40.1M |
| 4 |
COL
Rockwell Collins
COL
|
$36.9M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
$36.7M |
Top Sells
| 1 |
DRE
Duke Realty Corp.
DRE
|
$82.1M |
| 2 |
JWN
Nordstrom
JWN
|
$74.7M |
| 3 |
Brunswick
BC
|
$54.9M |
| 4 |
Newell Brands
NWL
|
$43.7M |
| 5 |
Boeing
BA
|
$40.8M |
Sector Composition
| 1 | Financials | 20.1% |
| 2 | Consumer Discretionary | 14.84% |
| 3 | Industrials | 13.22% |
| 4 | Healthcare | 11.11% |
| 5 | Technology | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Treehouse Foods
THS
$917M
| $50.8M | 0.53% |
585,858
+80,978
| +16% | +$7.02M |
|
|
AMSG
52
DELISTED
Amsurg Corp
AMSG
| $46.6M | 0.49% |
625,207
-2,285
| -0.4% | -$170K |
|
53
Aecom
ACM
$16.4B
| $44.8M | 0.47% |
1,453,494
-17,863
| -1% | -$550K |
|
|
CSC
54
DELISTED
Computer Sciences
CSC
| $43.7M | 0.46% |
1,270,316
+25,062
| +2% | +$862K |
|
|
DFT
55
DELISTED
DuPont Fabros Technology Inc.
DFT
| $43M | 0.45% |
1,061,599
-20,228
| -2% | -$820K |
|
56
Boston Scientific
BSX
$159B
| $42.7M | 0.45% |
2,270,799
+88,099
| +4% | +$1.66M |
|
57
General Dynamics
GD
$86.8B
| $42.5M | 0.44% |
323,709
+1,644
| +0.5% | +$216K |
|
58
Stryker
SYK
$149B
| $42M | 0.44% |
391,270
-2,920
| -0.7% | -$313K |
|
59
Amgen
AMGN
$153B
| $41.9M | 0.44% |
279,291
+30,416
| +12% | +$4.56M |
|
60
Pfizer
PFE
$141B
| $41.1M | 0.43% |
1,462,737
+228,371
| +19% | +$6.42M |
|
|
UN
61
DELISTED
Unilever NV New York Registry Shares
UN
| $41.1M | 0.43% |
918,778
+56,403
| +7% | +$2.52M |
|
62
Merck
MRK
$210B
| $40.7M | 0.42% |
805,264
+50,940
| +7% | +$2.57M |
|
63
Cardinal Health
CAH
$36B
| $40.6M | 0.42% |
495,842
+34,767
| +8% | +$2.85M |
|
64
Johnson & Johnson
JNJ
$429B
| $40.5M | 0.42% |
374,141
-18,890
| -5% | -$2.04M |
|
|
65
Gilead Sciences
GILD
$140B
| $40.5M | 0.42% |
+440,475
| New | +$40.5M |
|
66
Elevance Health
ELV
$72.4B
| $40.3M | 0.42% |
289,840
+22,630
| +8% | +$3.15M |
|
|
AET
67
DELISTED
Aetna Inc
AET
| $40.2M | 0.42% |
358,070
+11,465
| +3% | +$1.29M |
|
|
68
AbbVie
ABBV
$374B
| $40.1M | 0.42% |
+702,481
| New | +$40.1M |
|
69
STAG Industrial
STAG
$6.81B
| $40M | 0.42% |
1,964,047
-50,183
| -2% | -$1.02M |
|
70
Cencora
COR
$57.2B
| $40M | 0.42% |
461,966
+83,666
| +22% | +$7.24M |
|
71
AstraZeneca
AZN
$255B
| $39.9M | 0.42% |
1,416,079
+230,979
| +19% | +$6.5M |
|
72
Keurig Dr Pepper
KDP
$39.5B
| $39.8M | 0.41% |
445,177
+11,332
| +3% | +$1.01M |
|
73
EnerSys
ENS
$3.79B
| $39.4M | 0.41% |
707,283
-9,168
| -1% | -$511K |
|
|
ESRX
74
DELISTED
Express Scripts Holding Company
ESRX
| $39M | 0.41% |
567,944
+112,519
| +25% | +$7.73M |
|
75
Accenture
ACN
$158B
| $38.8M | 0.4% |
336,053
-55,472
| -14% | -$6.4M |
|